Sebastien Hazard
Direttore Tecnico/Scientifico/R&S presso IMUNON, INC.
Patrimonio netto: 23 200 $ in data 30/06/2024
Profilo
Sebastien Hazard is currently the Chief Medical Officer & Executive Vice President at Imunon, Inc. Prior to his current position, he held the role of Senior Medical Director-Clinical Development at Tesaro, Inc. from 2016 to 2019.
From 2019 to 2021, he served as the Head-Clinical Development at GSK Plc.
Dr. Hazard then joined Bicycle Therapeutics Plc in 2021 as the Senior VP & Head-Clinical Development, a position he held until 2023.
Hazard obtained an MBA from INSEAD.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IMUNON, INC.
0.21% | 07/12/2023 | 20 000 ( 0.21% ) | 23 200 $ | 30/06/2024 |
Posizioni attive di Sebastien Hazard
| Società | Posizione | Inizio |
|---|---|---|
| IMUNON, INC. | Direttore Tecnico/Scientifico/R&S | 11/12/2023 |
Precedenti posizioni note di Sebastien Hazard
| Società | Posizione | Fine |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01/09/2023 |
| GSK PLC | Direttore Tecnico/Scientifico/R&S | 01/04/2021 |
| TESARO INC | Direttore Tecnico/Scientifico/R&S | 01/05/2019 |
Formazione di Sebastien Hazard
| INSEAD | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| IMUNON, INC. | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| GSK PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Sebastien Hazard
